2025 Year-End Patient Centricity Review

Progress and Perspectives in Patient Centricity: 2025 Reflections

Patient centricity is a movement now. At Cactus Life Sciences, we don’t just follow the trend; we help set it. Here’s how your voices, our actions, and the industry’s bold steps made 2025 a landmark year...
Read More

Top Stories

Patient Centricity

The Evolution of Patient Centricity in Pharma

Patient centricity: A defining imperative in healthcare As...
AI in Scientific Publications

The Role of AI in Transforming Scientific

Scientific publishing is evolving rapidly with the advent of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Image - Understanding Patient Centricity, Progress Made, and Barriers Encountered Survey Questionnaire and Responses

Survey Report: Understanding Patient Centricity, Progress Made, and Barriers Encountered (Survey Questionnaire and Responses)

Cactus Communications commissioned a survey of pharma/biotech and associated industry professionals to understand the progress...

Engagement Strategies for the Digitally Savvy HCP

An infographic on engagement strategies for digitally savvy HCPs (Healthcare Professionals), by Cactus Life Sciences...
Plain language summaries

3 Interesting Facts about Plain Language Summaries

Did you know these 3 facts about plain language summaries?...
Strategic publication planning: A handy infographic for medical affairs

Strategic Publication Planning: Infographic for Medical Affairs

Here's a quick and easy-to-follow guide on for medical affairs teams on the what, how...
Pexels Alexander Suhorucov

Plain Language Summary Development in Japan: Current State and Challenges

This page contains supplementary information to support a poster presented at the Virtual 17th Annual...
Trends in publication review of articles

Review Article Publication Trends

This poster was presented by representatives from Cactus Life Sciences at the 11th Annual Meeting...

Learn more ABOUT our company.